These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 30424519

  • 61. Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection.
    Griffiths GD, Phillips GJ, Holley J.
    Inhal Toxicol; 2007 Aug; 19(10):873-87. PubMed ID: 17687718
    [Abstract] [Full Text] [Related]

  • 62. Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication.
    Mantis NJ, McGuinness CR, Sonuyi O, Edwards G, Farrant SA.
    Infect Immun; 2006 Jun; 74(6):3455-62. PubMed ID: 16714576
    [Abstract] [Full Text] [Related]

  • 63. A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking.
    Herrera C, Klokk TI, Cole R, Sandvig K, Mantis NJ.
    PLoS One; 2016 Jun; 11(6):e0156893. PubMed ID: 27300140
    [Abstract] [Full Text] [Related]

  • 64. A novel recombinant vaccine which protects mice against ricin intoxication.
    Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES.
    Vaccine; 2002 Sep 10; 20(27-28):3422-7. PubMed ID: 12213413
    [Abstract] [Full Text] [Related]

  • 65. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 10; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 66. Chimeric plantibody passively protects mice against aerosolized ricin challenge.
    Sully EK, Whaley KJ, Bohorova N, Bohorov O, Goodman C, Kim DH, Pauly MH, Velasco J, Hiatt E, Morton J, Swope K, Roy CJ, Zeitlin L, Mantis NJ.
    Clin Vaccine Immunol; 2014 May 10; 21(5):777-82. PubMed ID: 24574537
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. [Structure and properties of ricin – the toxic protein of Ricinus communis].
    Małajowicz J, Kuśmirek S.
    Postepy Biochem; 2019 Jun 06; 65(2):103-108. PubMed ID: 31642648
    [Abstract] [Full Text] [Related]

  • 69. Protection against ricin intoxication in vivo by anti-idiotype vaccination.
    Chanh TC, Hewetson JF.
    Vaccine; 1995 Apr 06; 13(5):479-85. PubMed ID: 7639015
    [Abstract] [Full Text] [Related]

  • 70. Purification, characterization and toxicity profile of ricin isoforms from castor beans.
    Sehgal P, Khan M, Kumar O, Vijayaraghavan R.
    Food Chem Toxicol; 2010 Nov 06; 48(11):3171-6. PubMed ID: 20728496
    [Abstract] [Full Text] [Related]

  • 71. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW.
    J Virol; 2016 Jan 20; 90(7):3515-29. PubMed ID: 26792737
    [Abstract] [Full Text] [Related]

  • 72. Ricin vaccine development.
    Smallshaw JE, Vitetta ES.
    Curr Top Microbiol Immunol; 2012 Jan 20; 357():259-72. PubMed ID: 21805396
    [Abstract] [Full Text] [Related]

  • 73. Active immunity induced by passive IgG post-exposure protection against ricin.
    Hu CC, Yin J, Chau D, Cherwonogrodzky JW, Hu WG.
    Toxins (Basel); 2014 Jan 21; 6(1):380-93. PubMed ID: 24451844
    [Abstract] [Full Text] [Related]

  • 74. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation.
    Griffiths GD, Phillips GJ, Bailey SC.
    Vaccine; 1999 Jun 04; 17(20-21):2562-8. PubMed ID: 10418903
    [Abstract] [Full Text] [Related]

  • 75. Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.
    Pratt TS, Pincus SH, Hale ML, Moreira AL, Roy CJ, Tchou-Wong KM.
    Exp Lung Res; 2007 Jun 04; 33(8-9):459-81. PubMed ID: 17994372
    [Abstract] [Full Text] [Related]

  • 76. Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial.
    Pittman PR, Reisler RB, Lindsey CY, Güereña F, Rivard R, Clizbe DP, Chambers M, Norris S, Smith LA.
    Vaccine; 2015 Dec 16; 33(51):7299-7306. PubMed ID: 26546259
    [Abstract] [Full Text] [Related]

  • 77. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, Wu H, Cummings JF, Elllingsworth L, Smith G.
    Vaccine; 2017 Jul 24; 35(33):4079-4087. PubMed ID: 28669616
    [Abstract] [Full Text] [Related]

  • 78. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge.
    Kende M, Yan C, Hewetson J, Frick MA, Rill WL, Tammariello R.
    Vaccine; 2002 Feb 22; 20(11-12):1681-91. PubMed ID: 11858879
    [Abstract] [Full Text] [Related]

  • 79. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 22; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 80. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
    Choi NW, Estes MK, Langridge WH.
    J Biotechnol; 2006 Jan 24; 121(2):272-83. PubMed ID: 16181698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.